Three-Year Clinical Outcomes of a Thin-Strut Biodegradable-Polymer Everolimus-Eluting Stent in Patients With Acute Coronary Syndrome

[1]  Teruo Inoue,et al.  Mobilization of progenitor cells and vessel healing after implantation of SYNERGY in acute coronary syndrome , 2021, Scientific Reports.

[2]  C. Terkelsen,et al.  Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention: A Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial). , 2019, JACC. Cardiovascular interventions.

[3]  Jeehoon Kang,et al.  The Evolving Concept of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: Focus on Unique Feature of East Asian and “Asian Paradox” , 2018, Korean circulation journal.

[4]  S. Buccheri,et al.  Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients. , 2017, JACC. Cardiovascular interventions.

[5]  C. Varenhorst,et al.  Real‐life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6]  S. Bangalore,et al.  Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents. , 2017, JACC. Cardiovascular interventions.

[7]  A. Kaltoft,et al.  Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial. , 2014, JACC. Cardiovascular interventions.

[8]  J. Fajadet,et al.  Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent. , 2012, Journal of the American College of Cardiology.

[9]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[10]  K. Yun,et al.  Clinical Outcomes Following SYNERGY Stent Implantation in a Prospective All-Comers Registry , 2022, Journal of Cardiovascular Intervention.